NDAINHALATIONAEROSOL, METERED
Approved
Nov 1967
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
BRONITIN MIST (epinephrine bitartrate) by Pfizer is 12. Approved for regional anesthesia, analgesia for surgery, dental and 4 more indications. First approved in 1967.
Drug data last refreshed 19h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
BRONITIN MIST is an inhaled epinephrine bitartrate aerosol approved in 1967 for acute bronchospasm relief and emergency respiratory support. It acts as a sympathomimetic agent that stimulates adrenergic receptors to dilate airways and improve breathing. The product is indicated for acute asthma attacks, bronchitis, and emergency respiratory conditions requiring rapid bronchodilation.
LOE Approaching
Product is nearing end-of-life with no active commercial expansion; team size expected to remain minimal or consolidate with legacy anesthetic/emergency care portfolio.
Mechanism of Action
12.1 Mechanism of Action Bupivacaine blocks the generation and the conduction of nerve impulses, presumably by increasing the threshold for electrical excitation in the nerve, by slowing the propagation of the nerve impulse, and by reducing the rate of rise of the action potential. In general, the…
Worked on BRONITIN MIST at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.